Future studies will be required to determine the translational significance of this finding in patients with diabetes, as it could lead to novel therapies that lower the incidence of hypoglycemia and improve glycemic control in insulin-treated patients, thereby mitigating their risk of developing micro- and macrovascular complications. This evidence concerns the gene INS and diabetes mellitus.